Literature DB >> 8257886

Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.

I Stensvold1, A Tverdal, P Urdal, S Graff-Iversen.   

Abstract

OBJECTIVE: To study the association between non-fasting serum triglyceride concentrations and mortality in women from coronary and cardiovascular disease and all causes.
DESIGN: Follow up by ambulatory teams of men and women who underwent cardiovascular screening for a mean of 14.6 years.
SETTING: National health screening service in Norway.
SUBJECTS: 25,058 men and 24,535 women aged 35-49 years. MAIN OUTCOME MEASURE: Predictive value of non-fasting serum triglyceride concentrations.
RESULTS: At initial screening total serum cholesterol concentration, serum triglyceride concentration, blood pressure, height, and weight were measured, and self reported information about smoking habits, physical activity, and time since last meal were recorded. During subsequent follow up 108 women died from coronary heart disease, 238 from cardiovascular diseases, and 931 from all causes. In women mortality increased steadily with increasing triglyceride concentration for all three causes of death. With the proportional hazards model and adjustment for age, systolic blood pressure, total cholesterol concentration, time since last meal, and number of cigarettes a day the relative risk between triglyceride concentration > or = 3.5 mmol/l and < 1.5 mmol/l was 4.7 (95% confidence interval 2.5 to 8.9) for deaths from coronary heart disease, 3.0 (1.9 to 4.8) for deaths from cardiovascular disease, 2.3 (1.8 to 2.9) for total deaths in all women.
CONCLUSIONS: A raised non-fasting concentration of triglycerides is an independent risk factor for mortality from coronary heart disease, cardiovascular disease, and any cause mortality among middle aged Norwegian women in contrast to what is seen in men.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257886      PMCID: PMC1679451          DOI: 10.1136/bmj.307.6915.1318

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

Review 1.  Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.

Authors:  M A Austin
Journal:  Am J Epidemiol       Date:  1989-02       Impact factor: 4.897

2.  The cardiovascular disease study in Norwegian counties. Background and organization.

Authors:  K Bjartveit; O P Foss; T Gjervig; P G Lund-Larsen
Journal:  Acta Med Scand Suppl       Date:  1979

3.  Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3.751 men aged 40-49.

Authors:  K Westlund; R Nicolaysen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

4.  A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66.

Authors:  H Natvig; C F Borchgrevink; J Dedichen; P A Owren; E H Schiotz; K Westlund
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters.

Authors:  G M Costongs; P C Janson; B M Bas; J Hermans; J W van Wersch; P J Brombacher
Journal:  J Clin Chem Clin Biochem       Date:  1985-01

6.  Genetic control of low-density-lipoprotein subclasses.

Authors:  M A Austin; R M Krauss
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

7.  Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease.

Authors:  S B Hulley; R H Rosenman; R D Bawol; R J Brand
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

Review 8.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

9.  High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women.

Authors:  I Stensvold; P Urdal; H Thürmer; A Tverdal; P G Lund-Larsen; O P Foss
Journal:  Eur Heart J       Date:  1992-09       Impact factor: 29.983

10.  Triglycerides--main lipid risk factor for cardiovascular disease in women?

Authors:  L Lapidus; C Bengtsson; O Lindquist; J A Sigurdsson; E Rybo
Journal:  Acta Med Scand       Date:  1985
View more
  31 in total

1.  A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.

Authors:  Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

2.  n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.

Authors:  Anne Hedengran; Pal B Szecsi; Jørn Dyerberg; William S Harris; Steen Stender
Journal:  Lipids       Date:  2014-11-18       Impact factor: 1.880

Review 3.  The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Authors:  Pratik B Sandesara; Salim S Virani; Sergio Fazio; Michael D Shapiro
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

4.  Plasma fibrinogen as cardiovascular risk factor.

Authors:  L Breimer
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

5.  Triglyceride concentration and coronary heart disease.

Authors:  A M Garber; A L Avins
Journal:  BMJ       Date:  1994-07-02

6.  Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State.

Authors:  Khendi T White; M V Moorthy; Akintunde O Akinkuolie; Olga Demler; Paul M Ridker; Nancy R Cook; Samia Mora
Journal:  Clin Chem       Date:  2015-06-12       Impact factor: 8.327

7.  The association between triglycerides and incident cardiovascular disease: What is "optimal"?

Authors:  Tsion Aberra; Eric D Peterson; Neha J Pagidipati; Hillary Mulder; Daniel M Wojdyla; Sephy Philip; Craig Granowitz; Ann Marie Navar
Journal:  J Clin Lipidol       Date:  2020-05-06       Impact factor: 4.766

8.  Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study.

Authors:  Anja S Lindman; M B Veierød; A Tverdal; J I Pedersen; R Selmer
Journal:  Eur J Epidemiol       Date:  2010-10-02       Impact factor: 8.082

9.  Daily stressors, past depression, and metabolic responses to high-fat meals: a novel path to obesity.

Authors:  Janice K Kiecolt-Glaser; Diane L Habash; Christopher P Fagundes; Rebecca Andridge; Juan Peng; William B Malarkey; Martha A Belury
Journal:  Biol Psychiatry       Date:  2014-07-14       Impact factor: 13.382

10.  Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can).

Authors:  Tanja Stocks; Wegene Borena; Susanne Strohmaier; Tone Bjørge; Jonas Manjer; Anders Engeland; Dorthe Johansen; Randi Selmer; Göran Hallmans; Kilian Rapp; Hans Concin; Håkan Jonsson; Hanno Ulmer; Pär Stattin
Journal:  Int J Epidemiol       Date:  2009-04-20       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.